S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 48.25 TWD 0.31% Market Closed
Market Cap: 5.8B TWD

Operating Margin
SCI Pharmtech Inc

11.4%
Current
13%
Average
6.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
11.4%
=
Operating Profit
159m
/
Revenue
1.4B

Operating Margin Across Competitors

No Stocks Found

SCI Pharmtech Inc
Glance View

Market Cap
5.8B TWD
Industry
Pharmaceuticals

SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others

Intrinsic Value
36.74 TWD
Overvaluation 24%
Intrinsic Value
Price
S
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
11.4%
=
Operating Profit
159m
/
Revenue
1.4B
What is the Operating Margin of SCI Pharmtech Inc?

Based on SCI Pharmtech Inc's most recent financial statements, the company has Operating Margin of 11.4%.

Back to Top